Updated hourlyHourly refreshTue, Oct 27, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Legal
NEW YORK, Oct. 24, 2026 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Webull Corporation (NASDAQ: BULL) between April 26, 2025 and October 6, 2026, both dates inclusive (the "Class Period"), of the important December 7, 2026 lead...
Oct 24 · 11:43·PR Newswire
Finance · Legal
NEW YORK, Oct. 24, 2026 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Ensign Group, Inc. (NASDAQ: ENSG) between February 10, 2022 and June 18, 2026, both dates inclusive (the "Class Period"), of the important December 7, 2026...
Oct 24 · 11:40·PR Newswire
Biotech & pharma
LAS VEGAS, Oct. 24, 2026 -- With a healthcare system that embraces both modern medicine and Traditional Chinese medicine (TCM), Taiwan brings together herbal knowledge passed down over millennia, scientific evidence and modern pharmaceutical and biotechnology capabilities....
Oct 24 · 11:38·PR Newswire
Finance · Banking
NEW YORK, Oct. 24, 2026 --
WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Bank of America Corporation (NYSE: BAC) between August 1, 2025 and October 13, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 15, 2026.
Oct 24 · 11:30·GlobeNewswire
AI · Healthcare
BEIJING, Oct. 24, 2026 -- Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer immunotherapies, sponsored and exhibited at the Abu Dhabi Future Health Summit 2026, held from 20 to 22 October at ADNEC Centre Abu Dhabi. The summit...
Oct 24 · 11:27·PR Newswire
Energy
Anti-tangle brush roll, 1.2-litre dust cup and a battery that clicks out, backed by a 60-day home trial and a five-year warranty MIAMI, FL / October 24, 2026 / Vekto today announced the launch of the Vekto Vacuum V18, a cordless stick vacuum that converts to a handheld. It is built around the three compl
Oct 24 · 11:25·ACCESS Newswire
Finance · Legal
NEW YORK, Oct. 24, 2026 --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lincoln Educational Services Corporation (NASDAQ: LINC) between May 11, 2026 and August 9, 2026, inclusive (the “Class Period”), of the important November 10, 2026 lead plaintiff deadline.
Oct 24 · 11:23·GlobeNewswire
Entertainment · Medical devices
Receiver-in-canal design streams phone calls and music to both ears, fits smaller ear canals and includes a 90-day home trial MIAMI, FL / October 24, 2026 / Certus Hearing today announced the launch of Certus Max, a certified rechargeable receiver-in-canal hearing aid for adults with perceived mild to mo
Oct 24 · 11:20·ACCESS Newswire
Finance · Legal
NEW YORK, Oct. 24, 2026 --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Qfin Holdings, Inc. (NASDAQ: QFIN) between March 18, 2026 and August 25, 2026, inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline.
Oct 24 · 11:18·GlobeNewswire
In the wire
Rebecca Ginder, LCSW (561-757-5887), a certified sex therapist in Boca Raton, has announced intimacy counseling and relationship therapy services for individuals and couples, available in-person and online throughout Florida. -- Rebecca Ginder has announced intimacy counseling and relationship therapy services for clients across Florida, addressing concerns including communication difficulties, desire differences, an
Oct 24 · 11:02·MarketersMEDIA
Finance · Healthcare
Phase 1/2 study will evaluate petosemtamab plus INCB161734 and standard-of-care chemotherapy in first-line KRAS G12D-mutated metastatic colorectal cancer (mCRC) COPENHAGEN, Denmark & WILMINGTON, Del., October 24, 2026--Genmab A/S (Nasdaq: GMAB) and Incyte (Nasdaq: INCY) today announced a clinical tria
Oct 24 · 11:01·Business Wire
Finance · Healthcare
Phase 1/2 study will evaluate INCB161734 plus petosemtamab and standard-of-care chemotherapy in first-line KRAS G12D-mutated metastatic colorectal cancer (mCRC) WILMINGTON, Del. & COPENHAGEN, Denmark, October 24, 2026--Incyte (Nasdaq:INCY) and Genmab A/S (Nasdaq:GMAB) today announced a clinical trial c
Oct 24 · 11:00·Business Wire